1-8 of 8
Anastasia Banti
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Caplacizumab for Acquired Thrombotic Thrombocytopenic Purpura: Real-World Multicenter Data on Re-Administration and Plasma Exchange Free Treatment

Eleni Gavriilaki, Evdoxia Koravou, Sotiria Dimou-Mpesikli, Emmanouil Nikolousis, Anastasia Banti, Charalampos Pontikoglou, Christina Kalpadakis, Aikaterini Bitsani, Iliana Tassi, Tasoula Touloumenidou, Thomas Chatzikonstantinou, Maria Papathanassiou, Antonia Syrigou, Eleutheria Ztriva, Georgia Kaiafa, Eudokia Mandala, Zois Mellios, Dimitrios Karakasis, Alexandra Kourakli, Argyris Symeonidis, Eleni Kapsali, Eleni Papadaki, Chrysavgi Lalayanni, Ioanna Sakellari
Journal: Blood
Blood (2022) 140 (Supplement 1): 8503–8504.
https://doi.org/10.1182/blood-2022-158549
Published: 2022
Journal Articles

Ruxolitinib Remains Effective in Myelofibrosis after the Necessary Dose Reductions: Real-Life Data from a Multi-Center Observational Study

Damianos Sotiropoulos, Vassilios Papadopoulos, Maria Dimou, Despoina Kyriakou, George Papaioannou, George Karavalakis, Chara Giatra, Alexandra Kourakli, Polyxeni Lampropoulou, Maria Palasopoulou, Anastasia Banti, Nora-Athina Viniou, Theodoros Marinakis, Eleftheria Hatzimichael, Evdoxia Hatjiharissi, Diamantina Vasilatou, Emmanuel Papadakis, George Vassilopoulos, MDPhD, Panagiotis Repousis, Taxiarchis Kourelis, Nikolaos Harhalakis, Argiris S. Symeonidis, Panayiotis Panayiotidis, MDPhD, Achilles Anagnostopoulos, MD
Journal: Blood
Blood (2016) 128 (22): 5476.
https://doi.org/10.1182/blood.V128.22.5476.5476
Published: 2016
Journal Articles

Ruxolitinib Efficacy and Safety in Myelofibrosis: A Multicenter Observational Study

Damianos Sotiropoulos, Vassilios Papadopoulos, Maria Dimou, Despoina Kyriakou, George Papaioannou, George Karavalakis, Emmanuel Papadakis, Maria Palasopoulou, Anastasia Banti, Taxiarchis Kourelis, Alexandra Kouraklis, Theodoros Marinakis, Nora-Athina Viniou, Eleftheria Hatzimichael, Diamantina Vasilatou, George Vassilopoulos, MDPhD, Panayiotis Panayiotidis, Achilles Anagnostopoulos
Journal: Blood
Blood (2015) 126 (23): 5192.
https://doi.org/10.1182/blood.V126.23.5192.5192
Published: 2015
Journal Articles

Thalidomide–Containing Regimens Induce Recovery of Normal Immunoglobulins in Newly Diagnosed Patients with Multiple Myeloma; Recovery of Normal Immunoglobulins Improves Survival.

Eirini Katodritou, MD, PhD, Evgenia Verrou, MD, Anastasia Banti, MD, Dimitra Mihou, MD, Vassiliki Gastari, MD, Christina Hadjiaggelidou, MD, Dimitra Markala, MD, Anna Lazaridou, MD, PhD, Evangelos Terpos, MD, PhD, Konstantinos Zervas, MD, PhD
Journal: Blood
Blood (2007) 110 (11): 2738.
https://doi.org/10.1182/blood.V110.11.2738.2738
Published: 2007
Journal Articles

The Ratio of Angiopoietin-1 to Angiopoietin-2 Is Reduced and Predicts Independently for Survival in Newly Diagnosed Patients with Multiple Myeloma.

Meletios A. Dimopoulos, Konstantinos Anargyrou, Eirini Katodritou, Efstathios Kastritis, Anastasia Pouli, Evridiki Michali, Evgenia Verrou, Anastasia Banti, Konstantinos Tsionos, Aikaterini Stefanoudaki, Konstantinos Zervas, Evangelos Terpos
Journal: Blood
Blood (2007) 110 (11): 1478.
https://doi.org/10.1182/blood.V110.11.1478.1478
Published: 2007
Journal Articles

Cystatin-C Is a Sensitive Marker of Renal Impairment with an Independent Predictive Value for Survival in Multiple Myeloma; Reduction Post Bortezomib Monotherapy.

Evangelos Terpos, Eirini Katodritou, Evangelos Tsiftsakis, Efstathios Kastritis, Anastasia Pouli, Dimitrios Christoulas, Evridiki Michali, Evgenia Verrou, Anastasia Banti, Konstantinos Tsionos, Meletios A. Dimopoulos, Konstantinos Zervas
Journal: Blood
Blood (2007) 110 (11): 1484.
https://doi.org/10.1182/blood.V110.11.1484.1484
Published: 2007
Journal Articles

The Addition of Thalidomide in Any Line of Treatment of Multiple Myeloma, Improves Overall Survival: Single Center Experience in 246 Patients.

Eirini Katodritou, MD, PhD, Evgenia Verrou, MD, Anastasia Banti, MD, Vassiliki Gastari, MD, Dimitra Mihou, MD, Christina Hadjiaggelidou, MD, Dimitra Markala, MD, Anna Lazaridou, MD, PhD, Evangelos Terpos, MD, PhD, Konstantinos Zervas, MD, PhD
Journal: Blood
Blood (2007) 110 (11): 4813.
https://doi.org/10.1182/blood.V110.11.4813.4813
Published: 2007
Journal Articles

Recombinant Human Erythropoietin May Negatively Influence Survival in Newly Diagnosed Patients with Multiple Myeloma: A Single Center Experience in 246 Patients.

Eirini Katodritou, MD, PhD, Evgenia Verrou, MD, Anastasia Banti, MD, Vassiliki Gastari, MD, Dimitra Mihou, MD, Christina Hadjiaggelidou, MD, Dimitra Markala, MD, Anna Lazaridou, MD, PhD, Evangelos Terpos, MD, PhD, Konstantinos Zervas, MD, PhD
Journal: Blood
Blood (2007) 110 (11): 4814.
https://doi.org/10.1182/blood.V110.11.4814.4814
Published: 2007